Description: The author discusses group short-term disability or STD programs, including the advantages and disadvantages of self insured vs. insured plans, as well as hybrid approaches.

Description: The viability and future outlook for the individual disability industry has dramatically improved from where it was 10 years ago. Evidence of this turn–around can be found in the industry's current profitability and its development of new markets. This article discusses where the market stands today.

Description: The presenters will discuss predictive analytics as applied to recent group life and disability experience studies and other applications.

Description: The 2013 Individual Disability Income Valuation Table (2013 IDIVT) approved by the NAIC as the new statutory minimum reserve morbidity basis.

Description: Report of the Task Force to Recommend Morbidity Standards for Valuation of Credit Disability. The key recommendation was that a new morbidity standard for valuation of policy reserves be adopted based on the tables developed by the Task Force. The tables are developed from the 85CIDA tables with incidence rates increased by 12%.

Description: An article that talks about the individual disability income IDI Market and how it is reaching out to Physicians. Issue No. 59

Description: Voluntary health insurance coverage options are described including hospital indemnity, accident plans, disability insurance, and critical illness policies.

Description: discussion of a new product idea for retirement planning which integrates a variety of needs estate death benefit, annuity income, disability income, etc. into one product

Description: This article discusses many of the complexities of the new IDI valuation table and how they might impact the implementation process.

Description: Report to give actuaries practical information and guidance on LTD claim credibility for case level pricing and underwriting. Stage 2 of the GLTD Credibility Study, this analysis was expanded using the industry data gathered during Stage 1.